Investing Profile

Paul Biondi

InvestorVC
President, Pioneering Medicines at Flagship Pioneering at Pioneering Medicines
Photo of Paul Biondi, President at Pioneering Medicines

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Northwestern University - Kellogg School of Management Network
264 CONNECTIONS
Dartmouth College Network
247 CONNECTIONS
Flagship Pioneering Network
98 CONNECTIONS
Flagship Pioneering Network
98 CONNECTIONS
Flagship Pioneering Network
98 CONNECTIONS
cb
$500K - $15.0M
$7.0M
1
CompanyStageDateRound SizeTotal Raised
Personal Genome Diagnostics
Series BJan 2018$75M
$200M
Co-investors: Justin Klein (Vensana Capital), Lily Li (Northpond Ventures)
President, Pioneering Medicines at Flagship Pioneering Pioneering Medicines2019 - Present
Senior Vice President, R&D Operations Bristol Myers SquibbPresent
Head of Business Development Bristol Myers SquibbPresent
President, Pioneering Medicines at Flagship Pioneering Flagship PioneeringPresent
Executive Partner Flagship VenturesPresent
General Partner Flagship PioneeringPresent
Managing Partner at Flagship Pioneering Flagship PioneeringPresent
Executive Partner Flagship Pioneering2019 - 2024
Head of Business Development Bristol-Myers Squibb2015 - 2019
Senior Vice President, R&D Operations Bristol-Myers Squibb2005 - 2015
Principal Mercer Management Consulting1993 - 2002
Northwestern University - Kellogg School of Management
Dartmouth College
Sign in with Google →
Sign in with Google →